Oxford Asset Management’s Editas Medicine EDIT Stock Holding History

Oxford Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27,425	Closed	-$812K	–	537
2019 Q4	$812K	Buy	27,425 +14,498	+112%	+$362K	0.02%	983
2019 Q3	$294K	Buy	+12,927	New	+$320K	0.01%	1465
2019 Q1	–	Sell	-56,931	Closed	-$1.29M	–	1736
2018 Q4	$1.29M	Buy	+56,931	New	+$1.55M	0.03%	716
2018 Q2	–	Sell	-11,365	Closed	-$377K	–	1753
2018 Q1	$377K	Buy	+11,365	New	+$405K	0.01%	1337

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oxford Asset Management's EDIT Position: Q1 2020 in Review

Oxford Asset Management sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 27,425 shares — an estimated $812K sold.

Oxford Asset Management first reported a position in EDIT in Q1 2018 and held it in 4 quarters. The position peaked at $1.29M in Q4 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

Oxford Asset Management reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 27,425 Editas Medicine shares in Q1 2020, an estimated $812K.
Oxford Asset Management first reported a position in Editas Medicine in Q1 2018 and held it in 4 quarters.
Oxford Asset Management's Editas Medicine position peaked at $1.29M in Q4 2018.
199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.